AMLX Stock-Based Compensation
Amylyx Pharmaceuticals Inc · Stock-Based Compensation
AMLX Stock-Based Compensation
Latest reported$27.90Mperiod ending
AMLX Stock-Based Comp ($108.00K → $27.90M)
Annual stock-based compensation
High-resolution chart · PNG
AMLX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 27,645,000 | |
| 33,038,000 | |
| 37,161,000 | |
| 21,714,000 | |
| 3,136,000 | |
| 243,000 | |
| 108,000 |